Anthem Biosciences has become the latest buzz in the IPO market after receiving an overwhelming response from investors. The much-anticipated IPO, which opened on July 14 and closed on July 16, is now moving into its allotment phase — scheduled for Wednesday, July 17.
Investors who participated in the IPO can now check whether they’ve been allotted shares. Let’s walk you through the allotment status process across BSE, NSE, and the registrar KFin Technologies.
📊 Anthem Biosciences IPO Overview
-
Price Band: ₹540 – ₹570 per share
Total Issue Size: 4,40,70,682 equity shares
-
IPO Subscription:
Overall: 63.86 times
-
QIBs: 182.65 times
-
NIIs: 42.36 times
-
Retail Investors: 5.64 times
-
Listing Date (Tentative): July 21 on NSE and BSE
The IPO also saw a strong start with ₹1,016 crore raised from anchor investors ahead of its opening.
🔍 How to Check Anthem Biosciences IPO Allotment Status Online
✅ 1. On the BSE Website
Step-by-step:
-
Visit: 👉 https://www.bseindia.com/investors/appli_check.aspx
Select ‘Equity’ under Issue Type
-
Choose ‘Anthem Biosciences Limited’ from the dropdown
-
Enter your Application Number and PAN
-
Complete the CAPTCHA and hit ‘Search’
✅ 2. On KFin Technologies Website (Registrar)
Option 1: Direct Link via Kosmic Platform
Select ‘Anthem Biosciences Ltd’ from the dropdown
-
Choose from:
Application Number
-
Demat Account Number
-
PAN
-
Choose application type: ASBA or Non-ASBA
-
Fill the required details and submit
- Option 2: Alternate KFin Portal
Visit: 👉 https://ris.kfintech.com/ipostatus/
-
Follow similar steps as above
✅ 3. On the NSE Website
Steps:
-
Visit: 👉 https://www.nseindia.com/invest/check-trades-bids-verify-ipo-bids
Click on ‘Equity & SME IPO bid details’
-
Select ‘Anthem Biosciences’
-
Enter your Application Number and PAN
-
Complete verification and click ‘Submit’
🔁 What Happens After Allotment?
-
✅ Allotted Shares: Will be credited to your Demat account before the listing date.
❌ Unallotted Shares: Your refund (if any) will be processed to your linked bank account.
🗓 What’s Next?
With listing expected on July 21, all eyes are on the market debut of Anthem Biosciences. Given the overwhelming subscription — especially from institutional investors — a strong listing gain could be on the cards.
📢 Stay Tuned: We'll update the blog with listing day highlights and post-listing performance soon.
🔁 Bookmark this page and share with fellow IPO investors!
0 Comments